174 related articles for article (PubMed ID: 38004435)
1. Experimental Evaluation of the Hypersensitivity Reactions of a New Glycopeptide Antibiotic Flavancin in Animal Models.
Treshchalin MI; Polozkova VA; Moiseenko EI; Shchekotikhin AE; Dovzhenko SA; Kobrin MB; Pereverzeva ER
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004435
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Toxic Properties of New Glycopeptide Flavancin on Rats.
Treshchalin MI; Polozkova VA; Moiseenko EI; Treshalina HM; Shchekotikhin AE; Pereverzeva ER
Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745578
[TBL] [Abstract][Full Text] [Related]
3. Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity.
Moiseenko EI; Erdei R; Grammatikova NE; Mirchink EP; Isakova EB; Pereverzeva ER; Batta G; Shchekotikhin AE
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33921612
[TBL] [Abstract][Full Text] [Related]
4. Glycopeptide Hypersensitivity and Adverse Reactions.
Huang V; Clayton NA; Welker KH
Pharmacy (Basel); 2020 Apr; 8(2):. PubMed ID: 32326261
[TBL] [Abstract][Full Text] [Related]
5. Anaphylactoid reactions to glycopeptide antibiotics.
Polk RE
J Antimicrob Chemother; 1991 Apr; 27 Suppl B():17-29. PubMed ID: 1711520
[TBL] [Abstract][Full Text] [Related]
6. Adverse reactions to vancomycin and cross-reactivity with other antibiotics.
De Luca JF; Holmes NE; Trubiano JA
Curr Opin Allergy Clin Immunol; 2020 Aug; 20(4):352-361. PubMed ID: 32590503
[TBL] [Abstract][Full Text] [Related]
7. In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455.
Yarlagadda V; Konai MM; Manjunath GB; Prakash RG; Mani B; Paramanandham K; Ranjan SB; Ravikumar R; Chakraborty SP; Roy S; Haldar J
Int J Antimicrob Agents; 2015 Jun; 45(6):627-34. PubMed ID: 25900818
[TBL] [Abstract][Full Text] [Related]
8. [Glycopeptide antibiotics: eremomycin, vancomycin, and teicoplanin. Comparison of several parameters of pharmacokinetics and antimicrobial activity].
Filippos'iants ST; Malkova IV; Gol'dberg LE
Antibiot Khimioter; 1989 Jul; 34(7):523-6. PubMed ID: 2530944
[TBL] [Abstract][Full Text] [Related]
9. [Eremomycin--a new antibiotic of the polycyclic glycopeptide group].
Gauze GF; Brazhnikova MG; Lomakina NN; Gol'dberg LE; Laĭko AV
Antibiot Khimioter; 1989 May; 34(5):348-52. PubMed ID: 2742419
[TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of a new glycopeptide antibiotic eremomycin in relation to obligate anaerobic Gram-positive bacteria].
Malkova IV; Borisova OK; Pavlova MV; Zemlianitskaia EP; Sergeeva TI
Antibiot Khimioter; 1991 Apr; 36(4):17-20. PubMed ID: 1654046
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study of the antibacterial activity and chemotherapeutic efficacy of the novel glycopeptide eremomycin].
Malikova IV
Antibiot Khimioter; 1989 Jan; 34(1):52-6. PubMed ID: 2543344
[TBL] [Abstract][Full Text] [Related]
12. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
[TBL] [Abstract][Full Text] [Related]
13. In vivo efficacy and pharmacological properties of a novel glycopeptide (YV4465) against vancomycin-intermediate Staphylococcus aureus.
Yarlagadda V; Konai MM; Paramanandham K; Nimita VC; Shome BR; Haldar J
Int J Antimicrob Agents; 2015 Oct; 46(4):446-50. PubMed ID: 26188396
[TBL] [Abstract][Full Text] [Related]
14. Redesign of glycopeptide antibiotics: back to the future.
James RC; Pierce JG; Okano A; Xie J; Boger DL
ACS Chem Biol; 2012 May; 7(5):797-804. PubMed ID: 22330049
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation and study of pseudo-allergic reactions of three kinds of traditional Chinese medicine injections and its mechanisms].
Yi Y; Li CY; Zhang YS; Zhao Y; Han JY; Lu YT; Liang AH
Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(14):2711-6. PubMed ID: 26666014
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study of histamine-liberating properties of eremomycin].
Filippos'iants ST; Shevniuk LA
Antibiot Khimioter; 1989 Mar; 34(3):209-12. PubMed ID: 2473716
[TBL] [Abstract][Full Text] [Related]
17. Histamine release and pseudoallergic reactions induced by radiographic contrast media: comparison of Angiographin, Hexabrix and Telebrix using an in vivo canine model.
Ennis M; Lorenz W; Schmal A; Dombrowski H
Agents Actions; 1990 Apr; 30(1-2):81-4. PubMed ID: 1695468
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial Conjugates of Kanamycin A with Vancomycin and Eremomycin: Biological Activity and a New MS-Fragmentation Pattern of Cbz-Protected Amines.
Solyev PN; Isakova EB; Olsufyeva EN
Antibiotics (Basel); 2023 May; 12(5):. PubMed ID: 37237799
[TBL] [Abstract][Full Text] [Related]
19. [Eremomycin--a new antibiotic from the cyclic glycopeptide group].
Gauze GF; Brazhnikova MG; Laĭko AV; Sveshnikova MA; Preobrazhenskaia TP
Antibiot Med Biotekhnol; 1987 Aug; 32(8):571-6. PubMed ID: 3674837
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
